DiGA Makers Report Decline as 74% Call Pay Inadequate
Berlin – October 30, 2026 -- All 34 digital health application (DiGA) companies surveyed by Bitkom report a worsening situation for manufacturers over the past two years, and 82% describe the deterioration as severe. Industry association Pharma Deutschland cited the findings in calling for reliable reimbursement and less bureaucracy for digital therapies.
Three in four manufacturers rate DiGA reimbursement as inadequate
74% of respondents consider current remuneration not or rather not appropriate relative to development, operating, evidence and approval effort. 85% see high development and approval costs as a drawback for economic viability, and 76% rate investment security as low.